HomeACRV • NASDAQ
add
Acrivon Therapeutics Inc
Previous close
$7.26
Day range
$7.14 - $7.38
Year range
$3.19 - $11.90
Market cap
221.76M USD
Avg Volume
115.65K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 21.44M | 38.12% |
Net income | -18.80M | -35.10% |
Net profit margin | — | — |
Earnings per share | -0.52 | 17.46% |
EBITDA | -21.21M | -37.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 180.54M | 19.60% |
Total assets | 230.58M | 44.07% |
Total liabilities | 14.53M | 33.70% |
Total equity | 216.06M | — |
Shares outstanding | 30.97M | — |
Price to book | 1.04 | — |
Return on assets | -30.53% | — |
Return on capital | -32.22% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -18.80M | -35.10% |
Cash from operations | -13.90M | -52.58% |
Cash from investing | -88.04M | -555.29% |
Cash from financing | 123.35M | 32,446.17% |
Net change in cash | 21.40M | 101.82% |
Free cash flow | -7.19M | -68.98% |
About
Founded
2018
Headquarters
Website
Employees
60
